ARCHIVES

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

This article is from The Cancer Letter archive.

Vol. 38 No. 36 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

NCI-Approved Clinical Trials

July 28, 2006

Bush Vetoes HHS Budget Bill, House Votes To Sustain.

November 23, 2007

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007